Literature DB >> 11012491

Determination of sevoflurane alveolar concentration for tracheal intubation with remifentanil, and no muscle relaxant.

A M Cros1, C Lopez, T Kandel, F Sztark.   

Abstract

The sevoflurane alveolar concentration needed for tracheal intubation with remifentanil was studied in 26 adult patients premedicated with 100 mg hydroxyzine. Anaesthesia was induced with sevoflurane in oxygen. The concentration was determined by Dixon's up-and-down method. The first patient was tested at 4.5%. One minute after obtaining the preselected value, remifentanil 1 microg.kg-1 was injected for 60 s followed by an infusion of 0.25 microg.kg-1. min-1. Ventilation was then manually assisted for 2 min and tracheal intubation was attempted. Tracheal intubation conditions and responses to intubation were noted. Heart rate and mean arterial pressure were recorded before induction, before remifentanil injection, and before and 3 min after tracheal intubation. The concentration for acceptable intubating conditions was 2.5 +/- 0.7%. From logistic regression, ED50 and ED95 were 2.0% (95% CI 1.3-2.5) and 3.2% (95% CI 2.6-5.6), respectively. With sevoflurane 2.5%, heart rate and mean arterial pressure decreased by 18% and 15%, respectively, after remifentanil administration and increased slightly after tracheal intubation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012491     DOI: 10.1046/j.1365-2044.2000.01538.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

Review 1.  Induction of anaesthesia: a guide to drug choice.

Authors:  Nathalie Nathan; Isabelle Odin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Global sensitivity analysis in physiologically-based pharmacokinetic/pharmacodynamic models of inhaled and opioids anesthetics and its application to generate virtual populations.

Authors:  Frank Sánchez Restrepo; Alher Mauricio Hernández Valdivieso
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-05-26       Impact factor: 2.410

3.  The effects of sevoflurane with propofol and remifentanil on tracheal intubation conditions without neuromuscular blocking agents.

Authors:  Wook Jong Kim; Seong Soo Choi; Doo Hwan Kim; Hye Jeong Seo; Eun Ha Suk; Seung Woo Ku; Pyung Hwan Park
Journal:  Korean J Anesthesiol       Date:  2010-08-20

4.  Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial.

Authors:  Thomas Mencke; Refa Maria Jacobs; Susann Machmueller; Martin Sauer; Christine Heidecke; Anja Kallert; Hans Wilhelm Pau; Gabriele Noeldge-Schomburg; Attila Ovari
Journal:  BMC Anesthesiol       Date:  2014-05-22       Impact factor: 2.217

5.  Sevoflurane at 1.0 MAC together with remifentanil and propofol produces clinically acceptable intubation conditions at the vocal cords: A prospective randomized study.

Authors:  Attila Ovari; Ilona Bicker; Susann Machmueller; Tobias Schuldt; Martin Sauer; Stefan Soltesz; Gabriele Noeldge-Schomburg; Robert Mlynski; Thomas Mencke
Journal:  J Int Med Res       Date:  2017-04-28       Impact factor: 1.671

6.  The optimal exhaled concentration of sevoflurane for intubation without neuromuscular blockade using clinical bolus doses of remifentanil: A randomized controlled trial.

Authors:  Eui-Kyoung Goo; Jong Seok Lee; Jae Chul Koh
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Supreme™ laryngeal mask airway insertion requires a lower concentration of sevoflurane than ProSeal™ laryngeal mask airway insertion during target-controlled remifentanil infusion: a prospective randomised controlled study.

Authors:  Cristina Monteserín-Matesanz; Tatiana González; María José Anadón-Baselga; Matilde Zaballos
Journal:  BMC Anesthesiol       Date:  2020-01-07       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.